144 results
425
EX-2.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
Litigation.
Section 3.10 Brokers’ and Finders’ Fees.
Section 3.11 Related Person Transactions.
Section 3.12 Employee Benefit Issues.
Section 3.13 Real … 4.05 Absence of Certain Changes or Events.
Section 4.06 Compliance; Permits.
Section 4.07 Litigation.
Section 4.08 Brokers.
Section 4.09 Information
8-K
EX-2.1
nylsa33
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-99.1
ozej8ody1
8 Dec 22
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
7:23pm
8-K
EX-4.3
zwmjmsahhbeh7fxs
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
7vozf87u8oarkbcbr
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-4.1
mkjyhg
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-99.1
z3jha0t5
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.2
2vm5k5i lt4f
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
DEF 14C
skszn 1n5gva1x4ro
2 Jun 22
Information statement
9:15am
PRE 14C
iwgrg
20 May 22
Preliminary information
9:22am